The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Open accessAbstract
In patients infected with the hepatitis C virus (HCV), 20% to 30% will progress to cirrhosis in over two to three decades. Viral and host factors that are important in the clinical and histologic progression of HCV infection are not entirely certain. It has been suggested that liver disease is worse in alcoholics infected with HCV. In the present retrospective study, we examined the effect of moderate alcohol intake on the histologic and clinical progression of HCV infection and assessed whether other variables such as gender, length of exposure, mode of exposure, HCV RNA levels, and ferritin levels also independently impacted disease progression. Liver biopsies were analyzed for the degree of fibrosis, presence of cirrhosis, and histologic activity by using the Histologic Activity Index of Knodell. Patients were divided into two groups based on whether their alcohol intake was significant or not significant. Significant alcohol intake was defined as >40 g alcohol/day in women and >60 g of alcohol/day in men for >5 years. Groups were further divided based on the decades of exposure to HCV. There was no difference in the age or length of exposure to HCV in the alcohol and the alcohol-free group. HCV RNA serum levels, ferritin levels, and viral genotypes were similar in both groups. There was a two- to threefold greater risk of liver cirrhosis and decompensated liver disease in the alcohol group. Also, the rate to which subjects developed cirrhosis was faster in the alcohol group with 58% being cirrhotic by the second decade as opposed to 10% being cirrhotic in the nonalcohol group by the second decade. The histologic and clinical acceleration of liver disease was independent of the mode of exposure or sex. In summary, alcohol intake is an independent risk factor in the clinical and histologic progression of HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y., et al. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-673 · Cited by 1,242
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C., & Christianini, G. (1994) · Hepatology · doi:10.1002/hep.1840200611 · Cited by 517
Hepatitis C Virus Type 1b (II) Infection in France and Italy
Nousbaum, J.-B., Pol, S., Nalpas, B., Landais, P., Berthelot, P., Brechot, C., & and The Collaborative Study Group* (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-3-199502010-00001 · Cited by 489
Roudot-Thoraval, F., Bastie, A., Pawlotsky, J., & Dhumeaux, D. (1997) · Hepatology · doi:10.1002/hep.510260233 · Cited by 297
To C or not to C: these are the questions
Alter, H. (1995) · Blood · doi:10.1182/blood.v85.7.1681.bloodjournal8571681 · Cited by 280
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
The natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
Parés, A., Barrera, J. M., Caballería, J., Ercilla, G., Bruguera, M., Caballería, L., Castillo, R., & Rodés, J. (1990) · Hepatology · doi:10.1002/hep.1840120608 · Cited by 230
Response to interferon α therapy is influenced by the iron content of the liver
Van Thiel, D. H., Friedlander, L., Fagiuoli, S., Wright, H. I., Irish, W., & Gavaler, J. S. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80017-0 · Cited by 209
Mendenhall, C. L., Seeff, L., Diehl, A. M., Ghosn, S. J., French, S. W., Gartside, P. S., Rouster, S. D., Buskell-Bales, Z., Grossman, C. J., Roselle, G. A., et al. (1991) · Hepatology · doi:10.1002/hep.1840140402 · Cited by 196
Increased Serum Hepatitis C Virus Rna Levels Among Alcoholic Patients With Chronic Hepatitis C
Oshita, M., Hayashi, N., Kasahara, A., Hagiwara, H., Mita, E., Naito, M., Katayama, K., Fusamoto, H., & Kamada, T. (1994) · Hepatology · doi:10.1002/hep.1840200503 · Cited by 188
Gordon, S. C., Elloway, R. S., Long, J. C., & Dmuchowski, C. (1993) · Hepatology · doi:10.1002/hep.1840180609 · Cited by 132
Hepatitis C virus genotypes are not responsible for development of serious liver disease
Yamada, M., Kakumu, S., Yoshioka, K., Higashi, Y., Tanaka, K., Ishikawa, T., & Takayanagi, M. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02090191 · Cited by 108
Nishiguchi, S., Kuroki, T., Yabusako, T., Seki, S., Kobayashi, K., Monna, T., Otani, S., Sakurai, M., Shikata, T., & Yamamoto, S. (1991) · Hepatology · doi:10.1002/hep.1840140606 · Cited by 105
Chronic Hepatitis C in Alcoholic Patients: Prevalence, Genotypes, and Correlation to Liver Disease
Befrits, R., Hedman, M., Blomquist, L., Allander, T., Grillner, L., Kinnman, N., Rubio‐Terres, C., & Hultcrantz, R. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509101616 · Cited by 85
Hepatitis C Virus in Alcoholic Patients with and without Clinically Apparent Liver Disease
COELHOLITTLE, M., Jeffers, L. J., Bernstein, D. E., Goodman, J. J., Reddy, K. R., de Medina, M. D., Li, X., Hill, M. A., Rue, S. L., & Schiff, E. R. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01597.x · Cited by 81
Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection
Strasser, S. I., Watson, K. J. R., Desmond, P. V., Lee, C. S., & Coghlan, P. (1995) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb139937.x · Cited by 64
Caldwell, S. H., Li, X., Rourk, R. M., Millar, A., Sosnowski, K. M., Sue, M. W., Barritt, A. S., McCallum, R. W., & Schiff, E. (1993) · PubMed · Cited by 58
Caldwell, S. H., Jeffers, L. J., Ditomaso, A., Millar, A., Clark, R. M., Rabassa, A., Reddy, K. R., Medina, M., & Schiff, E. R. (1991) · PubMed · Cited by 54
Kao, J., Tsai, S., Chen, P., Yang, P., Sheu, J., Lai, M., Hsu, H., Sung, J., Wang, T., & Chen, D. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80403-9 · Cited by 32
Cited by
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Lai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Metadata
- Authors
- Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J.
- Venue
- Hepatology
- Published
- 1998-09
- Volume
- 28
- Issue
- 3
- Pages
- 805-809
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2052723208
- Cited by
- 436
- References
- 24
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.